Internal Medicine, Pulmonary Disease · Sugar Land, TX
NPI
1497741037
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
16959 Southwest Fwy, Suite 100
Sugar Land, TX, 77479
Phone (832) 255-6632
Groups this clinician bills Medicare through
Medicare paid, 2024
$488K
8,089 services
Medicare patients, 2024
980
Average age 75
Drug cost, 2024
$4.1M
4,903 prescriptions
Company payments, 2025
$4,350
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandip R Desai was code 99214 (office e&m - established), 1,240 times for 570 patients. In total Sandip R Desai billed 8,089 services in 31 codes, and Medicare paid $488K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,240 | 570 | $99.02 | $123K |
| 99233 Hospital E&M - Subsequent | Facility | 1,064 | 324 | $97.26 | $103K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 788 | 96 | $0.34 | $272 |
| 99232 Hospital E&M - Subsequent | Facility | 570 | 118 | $64.57 | $37K |
| 96372 Injection Administration | Office | 550 | 129 | $11.41 | $6,277 |
| 99291 Critical Care E&M | Facility | 428 | 169 | $174.87 | $75K |
| 94726 Pulmonary Function Testing | Office | 370 | 367 | $44.77 | $17K |
| J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 368 | 356 | $0.15 | $55.03 |
| 94060 Pulmonary Function Testing | Office | 368 | 365 | $31.12 | $11K |
| 94729 Pulmonary Function Testing | Office | 362 | 359 | $45.46 | $16K |
| 94640 Treatment - Miscellaneous | Office | 354 | 333 | $6.40 | $2,264 |
| 99223 Hospital E&M - Initial | Facility | 266 | 223 | $141.18 | $38K |
| 99215 Office E&M - Established | Office | 150 | 111 | $140.47 | $21K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 135 | 65 | $0.22 | $29.87 |
| 99204 Office E&M - New | Office | 115 | 115 | $132.11 | $15K |
By year: 2022 $344K for 6,384 services; 2023 $433K for 7,091 services; 2024 $488K for 8,089 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sandip R Desai prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,031 prescriptions and refills. In total Sandip R Desai wrote 4,903 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,031 | 1,269 | 296 | $784K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 600 | 677 | 268 | $17K |
| Prednisone Generic | 480 | 553 | 320 | $2,243 |
| Montelukast Sodium Generic | 242 | 542 | 93 | $2,625 |
| Levofloxacin Generic | 222 | 222 | 189 | $1,695 |
| Dupixent Syringe Dupilumab | 197 | 215 | 34 | $797K |
| Fluticasone Propionate Generic | 150 | 253 | 74 | $2,388 |
| Fluconazole Generic | 124 | 124 | 109 | $1,623 |
| Levocetirizine Dihydrochloride Generic | 123 | 238 | 51 | $1,771 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 120 | 133 | 42 | $82K |
| Symbicort Budesonide/Formoterol Fumarate | 114 | 138 | 34 | $32K |
| Cefdinir Generic | 103 | 103 | 91 | $2,755 |
| Breo Ellipta Fluticasone/Vilanterol | 83 | 139 | 29 | $54K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 66 | 92 | 25 | $9,119 |
| Azithromycin Generic | 56 | 56 | 40 | $986 |
Brand drugs: 2,516 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandip R Desai $4,350 ($4,350 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $899.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 31 | $899 |
| Genzyme Corporation SNY | 20 | $787 |
| GlaxoSmithKline, LLC. GSK | 35 | $560 |
| Regeneron Healthcare Solutions, Inc. REGN | 21 | $419 |
| Insmed, Inc. INSM | 15 | $290 |
| Mallinckrodt Hospital Products Inc. | 9 | $182 |
| Actelion Pharmaceuticals US, Inc. JNJ | 5 | $154 |
| Verona Pharma, Inc. VRNA | 7 | $141 |
| Abiomed JNJ | 1 | $140 |
| Electromed, Inc. ELMD | 9 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.